Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
M. Sanchez-Luna
◽
R. Burgos-Pol
◽
I. Oyagüez
◽
J. Figueras-Aloy
◽
M. Sánchez-Solís
◽
...
2009 ◽
Vol 35
(1)
◽
pp. 4
◽
Gaetano Chirico
◽
Roberto Ravasio
◽
Urbano Sbarigia
2019 ◽
Vol 38
(11)
◽
pp. 1121-1125
◽
Matthew B. Jalink
◽
Joanne M. Langley
◽
Linda Dodds
◽
Pantelis Andreou
2015 ◽
Vol 9
(6)
◽
pp. 779-799
◽
Haben Y Abraha
◽
Krista L Lanctôt
◽
Bosco Paes
2007 ◽
Vol 96
(4)
◽
pp. 495-498
◽
Bernhard Resch
◽
Walter Gusenleitner
◽
Wilhelm D Mueller
1999 ◽
Vol 21
(4)
◽
pp. 752-766
◽
Albert Marchetti
◽
Helen Lau
◽
Raf Magar
◽
Liping Wang
◽
Giovanna Devercelli
2013 ◽
Vol 14
(2)
◽
pp. 130-136
◽
Bernhard Resch
◽
Elisabeth Resch
◽
Wilhelm Müller
2014 ◽
Vol 9
(10)
◽
pp. e110166
◽
Chyong-Hsin Hsu
◽
Chia-Ying Lin
◽
Hsin Chi
◽
Jui-Hsing Chang
◽
Han-Yang Hung
◽
...
2005 ◽
Vol 50
(5)
◽
pp. 397-403
◽
B. Resch
◽
A. Pasnocht
◽
W. Gusenleitner
◽
W. Müller
Gary M. Ginsberg
◽
Eli Somekh
◽
Yechiel Schlesinger
2013 ◽
Vol 16
(3)
◽
pp. A75
D. Rosselli
◽
J.D. Rueda
◽
J.G. Ruiz
Close
Export Citation Format
Close
Share Document
Close